BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev 2022;189:114485. [PMID: 35970274 DOI: 10.1016/j.addr.2022.114485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferreira MD, Duarte J, Veiga F, Paiva-Santos AC, Pires PC. Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy. Pharmaceutics 2023;15. [PMID: 36840000 DOI: 10.3390/pharmaceutics15020678] [Reference Citation Analysis]
2 Torres J, Costa I, Peixoto AF, Silva R, Sousa Lobo JM, Silva AC. Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases. Pharmaceuticals 2023;16:311. [DOI: 10.3390/ph16020311] [Reference Citation Analysis]
3 Law LH, Huang J, Xiao P, Liu Y, Chen Z, Lai JHC, Han X, Cheng GWY, Tse KH, Chan KWY. Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI. J Control Release 2023;354:208-20. [PMID: 36623695 DOI: 10.1016/j.jconrel.2023.01.011] [Reference Citation Analysis]
4 Ilić T, Đoković JB, Nikolić I, Mitrović JR, Pantelić I, Savić SD, Savić MM. Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. Pharmaceutics 2023;15. [PMID: 36839768 DOI: 10.3390/pharmaceutics15020443] [Reference Citation Analysis]
5 Miao YB, Zhao W, Renchi G, Gong Y, Shi Y. Customizing delivery nano-vehicles for precise brain tumor therapy. J Nanobiotechnology 2023;21:32. [PMID: 36707835 DOI: 10.1186/s12951-023-01775-9] [Reference Citation Analysis]
6 Wu W, Li T. Deepening the understanding of the in vivo and cellular fate of nanocarriers. Adv Drug Deliv Rev 2022;189:114529. [PMID: 36064031 DOI: 10.1016/j.addr.2022.114529] [Reference Citation Analysis]